To clarify the basis of macrolide therapy for improvement of chronic sinusitis, we investigated the effect of macrolides on the expression of HLA-DR and costimulatory molecules such as CD54 and CD80 on macrophages in nasal polyps. Nasal polyps taken from 54 patients who had or had not been treated with macrolides were immunohistochemically studied. The percentages of CD68-positive macrophages expressing HLA-DR or CD54 were not significantly different between patients treated with macrolides and those not treated with macrolides. However, among patients exhibiting no atopic predisposition, the number of CD80-positive macrophages was higher in patients treated with macrolides than in those not treated. In addition, the percentage of CD80-positive macrophages was negatively correlated with the percentage of infiltrating eosinophils in the polyps. These results demonstrate that macrophages act as antigen-presenting cells, expressing both major histocompatibility complex II and costimulators, and that the expression of CD80 may play a key role in the immune responses occurring in a nasal polyp. Macrolides may modulate the mucosal immune responses through CD80 expression.
JanewayCAJrBottomlyK. Signals and signs for lymphocyte responses. Cell1994; 76: 275–85.
2.
GuinanECGribbenJGBoussiotisVAFreemanGJNadlerLM. Pivotal role of the B7: CD28 pathway in transplantation tolerance and tumor immunity. Blood1994; 84: 3261–82.
3.
KuchrooVKDasMPBrownJA. B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapy. Cell1995; 80: 707–18.
KudohSUetakeTHagiwaraK. Clinical effects of low-dose long-term erythromycin chemotherapy on diffuse panbronchiolitis [in Japanese]. Jpn J Thorac Dis1987; 25: 632–42.
6.
KikuchiSSuzakiHAokiAItoONomuraY. Clinical effect of long-term low-dose erythromycin therapy for chronic sinusitis [in Japanese]. Pract Otol (Kyoto)1991; 84: 41–7.
7.
TakagitaSKitamuraHNishikawaA. Clinical effect of low-dose erythromycin chemotherapy on chronic sinusitis [in Japanesel. Pract Otol (Kyoto)1991: 84: 489–98.
8.
IinoYSugitaKToriyamaMKudoK. Erythromycin therapy for otitis media with effusion in sinobronchial syndrome. Arch Otolaryngol Head Neck Surg1993: 119: 648–51.
9.
StoopAEvan der HeijdenHAMDBiewengaJvan der BaanS. Lymphocytes and nonlymphoid cells in human nasal polyps. J Allergy Clin Immunol1991; 87: 470–5.
10.
LinoYToriyamaMKudoKNatoriYYuoA. Erythromycin inhibition of lipopolysaccharide-stimulated tumor necrosis factor alpha production by human monocytes in vitro. Ann Otol Rhinol Laryngol Suppl1992; 101(suppl 157): 16–20.
11.
TakeshitaKYamagishiIHaradaMOtomoSNakagawaTMizushimaY. Immunological and anti-inflammatory effects of clarithromycin: Inhibition of interleukin 1 production of murine peritoneal macrophages. Drugs Exp Clin Res1989; 15: 527–33.
12.
AndersonRFernandesACEftychisHE. Studies on the effects of ingestion of a single 500 mg oral dose of erythromycin stearate on leucocyte motility and transformation and on release in vitro of prostaglandin E2 by stimulated leucocytes. J Antimicrob Chemother1984; 14: 41–50.
13.
AndersonR. Erythromycin and roxithromycin potentiate human neutrophil locomotion in vitro by inhibition of leukoattractant-activated superoxide generation and autooxidation. J Infect Dis1989; 159: 966–73.
14.
RocheYGougerot-PocidaloMAFayMForestNPocidaloJJ. Macrolides and immunity: Effects of erythromycin and spiramycin on human mononuclear cell proliferation. J Antimicrob Chemother1986: 17: 195–203.
15.
MiyazawaTLinoY. Cell surface antigens on inflammatory cells in the paranasal mucosa of patients after macrolide therapy [in Japanese],J Otolaryngol Jpn1997; 100: 671–7.
16.
HamilosDLLeungDYMWoodR. Evidence for distinct cytokine expression in allergic versus nonallergic chronic sinusitis. J Allergy Clin Immunol1995; 96: 537–44.
17.
PoulterLWCampbellDAMunroCJanossyG. Discrimination of human macrophages and dendritic cells by means of monoclonal antibodies. Scand J Immunol1986; 24: 351–7.
18.
DamleNKKlussmanKLinsleyPSAruffoA. Differential costimulatory effects of adhesion molecules B7, ICAM-1, LFA-3, and VCAM-1 on resting and antigen-primed CD4+ T lymphocytes. J Immunol1992: 148: 1985–92.
19.
DamleNK. Klussman K, Linsley PS, Aruffo A, Ledbetter JA. Differential regulatory effects of intercellular adhesion molecule-1 on costimulation by the CD28 counter-receptor B7. J Immunol1992: 149: 2541–8.
20.
EnomotoFIchikawaGNagaokaIYamashitaY. Effect of erythromycin on otitis media with effusion in experimental rat model. Acta Otolaryngol Suppl (Stockh)1998(suppl 539): 57–60.
21.
OkuboY. Macrolides reduce the expression of surface Mac-1 molecule on neutrophil. Kurume Med J1997; 44: 115–23.
22.
DamleNKKlussmanKLeytzeG. Costimulation of T lymphocytes with integrin ligands intercellular adhesion molecule–1 or vascular cell adhesion molecule–1 induces functional expression of CTLA-4, a second receptor for B7. J Immunol1994; 152: 2686–97.
23.
LinoYOkuraSShigaJToriyamaMKudoK. Histopathological studies on paranasal mucosa from patients treated with erythromycin [in Japanese]. J Otolaryngol Jpn1994: 97: 1070–8.
24.
GajewskiTFLanckiDWStackRFitchFW. “Anergy” of Th0 helper T lymphocytes induces downregulation of Th1 characteristics and a transition to a Th2-like phenotype. J Exp Med1994; 179: 481–91.
25.
OhnoILeaRFinottoS. Granulocyte/macrophage colony-stimulating factor (GM-CSF) gene expression by eosinophils in nasal polyposis. Am J Respir Cell Mol Biol1991; 5: 505–10.
26.
BachertC. Cytokines: Comparison between polyp tissue, diseased sinus mucosa and normal nasal tissue. In: MygindNLildholdtTNasal polyposis: an inflammatory disease and its treatment. Copenhagen, Denmark: Munksgaard, 1997: 98–104.
